UA74404C2 - Производные пиридинзамещенных пиразолопиридинов - Google Patents
Производные пиридинзамещенных пиразолопиридиновInfo
- Publication number
- UA74404C2 UA74404C2 UA2003065752A UA200365752A UA74404C2 UA 74404 C2 UA74404 C2 UA 74404C2 UA 2003065752 A UA2003065752 A UA 2003065752A UA 200365752 A UA200365752 A UA 200365752A UA 74404 C2 UA74404 C2 UA 74404C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pyrazolopyridine
- substituted derivatives
- pyridine substituted
- diseases
- treating
- Prior art date
Links
- MIPXMNHVROTWNG-UHFFFAOYSA-N 1H-pyrazolo[4,3-b]pyridine pyridine Chemical group C1=CC=NC=C1.C1=CN=C2C=NNC2=C1 MIPXMNHVROTWNG-UHFFFAOYSA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010020852 Hypertonia Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 102000007637 Soluble Guanylyl Cyclase Human genes 0.000 abstract 1
- 108010007205 Soluble Guanylyl Cyclase Proteins 0.000 abstract 1
- 208000001435 Thromboembolism Diseases 0.000 abstract 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 150000005229 pyrazolopyridines Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Настоящее изобретение касается новых производных пиразолопиридина формулы (І), в которой R1 4-означает пиридинил 3-или пиридинил, R2 означает водород, NH2 или галоген, а также солей, изомеров и гидратов этих соединений, которые предназначены для использования как стимуляторы растворимой гуанилатциклазы и лекарственных средств для лечения заболеваний кровообращения сердца, гипертонии, тромбоэмболических болезней, ишемии, сексуальной дисфункции, заболеваний центральной нервной системы, а также как противовоспалительное средство.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10057753 | 2000-11-22 | ||
| DE10131987A DE10131987A1 (de) | 2000-11-22 | 2001-07-02 | Neue Pyridin-substituierte Pyrazolopyridinderivate |
| PCT/EP2001/012969 WO2002042301A1 (de) | 2000-11-22 | 2001-11-09 | Neue pyridin-substituierte pyrazolopyridinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA74404C2 true UA74404C2 (ru) | 2005-12-15 |
Family
ID=7664122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2003065752A UA74404C2 (ru) | 2000-11-22 | 2001-11-09 | Производные пиридинзамещенных пиразолопиридинов |
Country Status (12)
| Country | Link |
|---|---|
| KR (1) | KR20030065519A (ru) |
| DE (2) | DE10131987A1 (ru) |
| DO (1) | DOP2001000291A (ru) |
| EC (1) | ECSP034616A (ru) |
| GT (1) | GT200100235A (ru) |
| HN (1) | HN2001000261A (ru) |
| MY (1) | MY127212A (ru) |
| PE (1) | PE20020581A1 (ru) |
| RU (1) | RU2003118584A (ru) |
| SV (1) | SV2003000743A (ru) |
| UA (1) | UA74404C2 (ru) |
| ZA (1) | ZA200303887B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102485724B (zh) * | 2010-12-06 | 2015-08-12 | 中国人民解放军军事医学科学院毒物药物研究所 | 取代噻吩基吡唑并吡啶类化合物及其医药用途 |
| ES2603028T3 (es) | 2011-11-25 | 2017-02-23 | Adverio Pharma Gmbh | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos |
| EP3525779B1 (de) * | 2016-10-11 | 2024-06-05 | Bayer Pharma Aktiengesellschaft | Kombination enthaltend den sgc stimulator vericuguat und den mineralcorticoid-rezeptor-antagonist finerenone |
-
2001
- 2001-07-02 DE DE10131987A patent/DE10131987A1/de not_active Withdrawn
- 2001-11-09 KR KR10-2003-7006853A patent/KR20030065519A/ko not_active Withdrawn
- 2001-11-09 UA UA2003065752A patent/UA74404C2/ru unknown
- 2001-11-09 DE DE50106655T patent/DE50106655D1/de not_active Expired - Lifetime
- 2001-11-09 RU RU2003118584/04A patent/RU2003118584A/ru not_active Application Discontinuation
- 2001-11-20 DO DO2001000291A patent/DOP2001000291A/es unknown
- 2001-11-20 MY MYPI20015302A patent/MY127212A/en unknown
- 2001-11-21 PE PE2001001161A patent/PE20020581A1/es not_active Application Discontinuation
- 2001-11-21 HN HN2001000261A patent/HN2001000261A/es unknown
- 2001-11-21 SV SV2001000743A patent/SV2003000743A/es unknown
- 2001-11-22 GT GT200100235A patent/GT200100235A/es unknown
-
2003
- 2003-05-19 ZA ZA200303887A patent/ZA200303887B/en unknown
- 2003-05-21 EC EC2003004616A patent/ECSP034616A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP034616A (es) | 2003-06-25 |
| MY127212A (en) | 2006-11-30 |
| RU2003118584A (ru) | 2004-12-20 |
| PE20020581A1 (es) | 2002-07-13 |
| GT200100235A (es) | 2002-06-25 |
| KR20030065519A (ko) | 2003-08-06 |
| DE10131987A1 (de) | 2002-05-23 |
| DOP2001000291A (es) | 2002-12-15 |
| HN2001000261A (es) | 2002-01-30 |
| ZA200303887B (en) | 2004-06-21 |
| SV2003000743A (es) | 2003-01-13 |
| DE50106655D1 (de) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03004500A (es) | Nuevos derivados de pirazolopiridina sustituidos con piridina. | |
| BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
| AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| MXPA04004370A (es) | Derivados policiclicos de guanina inhibidores de fosfodiesterasa v. | |
| WO2001056990A3 (en) | Pyridine derivates as potentiators of glutamate receptors | |
| GEP20022676B (en) | 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors | |
| MXPA05002442A (es) | Imidazolopiridinas y metodos para la elaboracion y uso de las mismas. | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| MXPA05002443A (es) | Pirazolopiridinas y metodos para elaboracion y uso de las mismas. | |
| MXPA02011370A (es) | Iminoazinas substituidas. | |
| YU99702A (sh) | Derivati sulfonil-pirolidina | |
| MXPA03005601A (es) | Nuevos compuestos y composiciones como inhibidores de catepsina. | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| PL372409A1 (en) | Novel alkoxypyridine-derivatives | |
| MXPA03002909A (es) | Compuestos quimicos. | |
| SI1532131T1 (sl) | Motilidne spojine | |
| PT1673354E (pt) | Arilindenopiridinas e arilindenopirimidinas e sua utilização como antagonistas do receptor da adenosina a2a | |
| BG103867A (en) | Cyanoguanidines as cell proliferation inhibitors | |
| GB9711123D0 (en) | Novel cyanoguanidines | |
| UA74404C2 (ru) | Производные пиридинзамещенных пиразолопиридинов | |
| IL161842A0 (en) | 2-Amino-4-heteroarylethyl-thiazoline derivatives and their use as inhibitors of inducible no-synthase | |
| AR027134A1 (es) | Derivados de indol. | |
| EP1400522A4 (en) | NEW COMPOUNDS FOR THE TREATMENT OF IMPUSE | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| MXPA04005185A (es) | Compuestos hexaciclicos. |